A Study Testing an Improved Dose of UM171 to Help Make Cord Blood Transplants More Effective and Safe.

Clinical trial NCT07301866 · RECRUITING

Trial details

NCT number: NCT07301866
Sponsor: Ciusss de L'Est de l'Île de Montréal
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Acute Leukemia, High Risk Myelodysplastic Syndromes, High Risk Hematologic Malignancy Requiring an Allogeneic Hematopoietic Stem Cell Transplant Lacking a Donor

Start date: 2025-10-06
Primary completion: 2027-10-01
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.